A commercially available monoclonal antibody directed against an early nuclear protein of cytomegalovirus was used with low-speed centrifugation for the rapid detection of this virus from urine specimens inoculated onto MRC-5 cells. A total of 19 of 162 (11.7%) urine specimens inoculated were positive by both immunofluorescence and peroxidase-antiperoxidase procedures (sensitivity, 100%), whereas only 18 of the samples produced cytopathic effects in conventional cell culture (specificity, 94.7%). All specimens were positive by immunofluorescence and peroxidase-antiperoxidase procedures at 36 h postinfection, whereas an average of 9 days was required for cytopathic effects to develop in cell cultures.
A commercially available monoclonal antibody directed against an early nuclear protein of cytomegalovirus was used with low-speed centrifugation for the rapid detection of this virus from urine specimens inoculated onto MRC-5 cells. A total of 19 of 162 (11.7%) urine specimens inoculated were positive by both immunofluorescence and peroxidase-antiperoxidase procedures (sensitivity, 100%), whereas only 18 of the samples produced cytopathic effects in conventional cell culture (specificity, 94.7%). All specimens were positive by immunofluorescence and peroxidase-antiperoxidase procedures at 36 h postinfection, whereas an average of 9 days was required for cytopathic effects to develop in cell cultures.
Cytomegalovirus (CMV) causes severe infections in congenitally infected infants, immunosuppressed patients such as transplant recipients or individuals receiving therapy for neoplastic disease, and in patients with acquired immunodeficiency syndrome. Because of the expanding importance of CMV in clinical medicine, rapid routine diagnostic methods in the clinical laboratory are needed for the diagnosis of CMV infections. Cell culture isolation by conventional techniques generally requires 7 to 21 days for recognition of characteristic cytopathic effect (CPE) (14) . Low-speed centrifugation of specimen inoculum onto cell culture monolayers has been shown to increase the efficiency of infection with several intracellular organisms, such as Chlamydia spp. (10) , murine CMV, and the AD169 strain of human CMV (5, 7). We combined this technique with the use of a monoclonal antibody (2H2.4) directed against an early nuclear protein of CMV with a molecular weight of 72,000 in immunofluorescence (IF) and peroxidase-antiperoxidase (PAP) tests for the rapid detection of CMV in urine specimens inoculated onto MRC-5 cells from renal transplant recipients, congenitally infected infants, and other immunosuppressed patients. By comparing them with conventional cell culture isolation of CMV, we found that the IF and PAP tests subsequent to the centrifugation step detected CMV infections earlier than cell culture CPE tests in all specimens.
Human diploid fibroblast (MRC-5) cells were obtained from Flow Laboratories, Rockville, Md. Eagle minimal essential medium (MEM) containing 10% fetal bovine serum, penicillin, streptomycin, and gentamicin was used (11) .
The CMV strain AD169 was used for the preparation of monoclonal antibody directed to the 72,000-dalton early nuclear protein of this strain (E. A. Shuster, J. S. Beneke, G. E. Tegtmeier, and G. R. Pearson, manuscript in preparation) and can be commercially obtained from Biotech Research Laboratories, Inc., Rockville, Md.
MRC-5 cells were subcultured to culture tubes (16 by 125 mm) and maintained with MEM until inoculation of specimens. When received, urine specimens were inoculated into two MRC-5 cell culture tubes (0.2 ml per tube), placed on a * Corresponding author.
roller drum at 36°C, and subsequently examined at x 125 for typical CPE due to CMV (11) .
MRC-5 cells were seeded (50,000 cells per ml) into 1-dram (ca. 3.7-ml) shell vials, each containing a 12-mm round cover slip and maintained with MEM until use. Before inoculation, MEM was removed from the shell vial, and 0.1 ml of the urine specimen (four shell vials per specimen) was placed directly onto the cell monolayer. The shell vials were closed with rubber stoppers, placed in carriers, and centrifuged at room temperature at 700 x g for 1 h in a centrifuge (Sorvall RT6000; DuPont Co., Wilmington, Del.) Shell vials were also inoculated as described, but not centrifuged (four vials per specimen) and were held at room temperature for viral adsorption. After viral adsorption and centrifugation, 1.0 ml of MEM was added back to each vial, and the cultures were incubated at 36°C. At 36 and 96 h postinfection, the cover slips (two cover slips each time) were removed from the vials, washed two times with phosphate-buffered saline, and fixed with cold acetone for 20 min. Cell monolayers on the cover slips were then stained by the indirect IF test and PAP test methods (11, 12) , with the monoclonal antibody 2H2.4 as the primary antibody for CMV detection in the cell monolayers. Controls consisted of a known strain of CMV inoculated, centrifuged, and stained as for specimens described above.
Briefly, the staining procedures were as follows. The cell monolayers were treated with the monoclonal CMV antibody 2H2.4 for 30 min at 36°C. Monolayers were then stained by the indirect IF method (11) by using goat antimouse immunoglobulin G-fluorescein isothiocyanate-labeled conjugate (Cappel Laboratories, Westchester, Pa.). In the PAP test, a goat anti-mouse antibody (Cappel) was used as the linking antibody between the monoclonal antibody to CMV and the PAP complex of mouse origin (DAKO, Accurate Chemical and Scientific Corp., Westbury, N.Y.). The substrate chromogen 3-amino-9-ethyl carbazole (ICN Pharmaceuticals, Inc., Plainview, N.Y.) was prepared by the method of Corey et al. (2) .
MRC-5 cells were suspended in MEM containing iododeoxyuridine (Smith Kline & French Laboratories, Philadelphia, Pa.) (100 ,ug/ml, final concentration) and grown in shell vials for 48 to 72 h. Iododeoxyuridine medium was removed J. CLIN. MICROBIOL. before inoculation of the shell vials (two vials per specimen) with specimens (9, 13) .
CPE typical of that produced by CMV was detected in 18 of 162 (11.1%) urine specimens by CPE in conventional cell cultures, requiring an average time of 9 days. A total of 19 specimens processed in shell vials using 2H2.4 as the primary antibody were positive by both IF and PAP procedures at 36 h postinfection (Table 1) . Typical nuclear localization ing the shell vial cover slip can be adjusted to an earlier time such as 16 to 18 h in addition to the 36 h assay. We have observed detection of CMV from fresh urine specimens at 16 h postinfection and are currently using this assay in our diagnostic laboratory as a routine test procedure for CMV detection from urine, lung, and blood specimens at 16 and 36 h postinfection. In addition, IF and PAP procedures were comparable so that either test could be used to take advantage of existing laboratory capabilities.
In the past, the availability of polyclonal antibody to CMV was inconsistent. Our commercially available monoclonal antibody should provide a consistent and reliable reagent for the detection of this viral pathogen. The centrifugation enhancement technique, in addition to the use of the monoclonal antibody for detecting CMV, should be extended to lung tissue and blood specimens to provide a more rapid report time than conventional cell cultures for systemic infection.
